Related references
Note: Only part of the references are listed.Regulation of metabolism by the innate immune system
Denise E. Lackey et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects
S. R. Mirhafez et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
S100A8/A9: From basic science to clinical application
Monika Pruenster et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Effect of different bariatric surgery type on the leukocyte formula
Filipe M. Cunha et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Gastric bypass surgery reveals independency of obesity and diabetes melitus type 2
Mogens Fenger et al.
BMC ENDOCRINE DISORDERS (2016)
Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus
Christian Lood et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Adipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
Ayano Kohlgruber et al.
CURRENT DIABETES REPORTS (2015)
Association of Peripheral Total and Differential Leukocyte Counts with Obesity-Related Complications in Young Adults
Aya Yoshimura et al.
OBESITY FACTS (2015)
Roux-en-Y Gastric Bypass Decreases Pro-inflammatory and Thrombotic Biomarkers in Individuals with Extreme Obesity
Barbara Dal Molin Netto et al.
OBESITY SURGERY (2015)
Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity
Prabhakara R. Nagareddy et al.
CELL METABOLISM (2014)
Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass
Kirstine N. Bojsen-Moller et al.
DIABETES (2014)
Macrophages, Immunity, and Metabolic Disease
Joanne C. McNelis et al.
IMMUNITY (2014)
From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
Martin Pal et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis
Prabhakara R. Nagareddy et al.
CELL METABOLISM (2013)
Inflammatory Markers and Risk of Type 2 Diabetes A systematic review and meta-analysis
Xia Wang et al.
DIABETES CARE (2013)
Three-month treatment with pioglitazone reduces circulating levels of S100A8/A9 (MRP8/14) complex, a biomarker of inflammation, without changes in body mass index, in type 2 diabetics with abdominal obesity
Hideaki Nakatsuji et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes
Francisco J. Ortega et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss
Victoria Catalan et al.
MOLECULAR MEDICINE (2011)
Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery
Gary D. Miller et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2011)
The major inflammatory mediator interleukin-6 and obesity
Katalin Eder et al.
INFLAMMATION RESEARCH (2009)
Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute Inflammation
Jeroen Nijhuis et al.
OBESITY (2009)
Serum C-Reactive Protein and White Blood Cell Count in Morbidly Obese Surgical Patients
Sheng-Bin Chen et al.
OBESITY SURGERY (2009)
Calprotectin - A Novel Marker of Obesity
Ole Hartvig Mortensen et al.
PLOS ONE (2009)
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia
Y Herishanu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Use and abuse of HOMA modeling
TM Wallace et al.
DIABETES CARE (2004)
Share Paper
